Pediatric Cancer Articles & Analysis
13 news found
” “Since their inception, the UofL Health – Brown Cancer Center GMP Manufacturing Facility and the Dunbar CAR T-Cell Program at the University of Louisville have been committed to bringing these lifesaving immunotherapies to adult and pediatric cancer patients throughout Kentucky and the region. ...
“xCures is pleased to continue our efforts to bring pre-approval access to investigational medications for pediatric cancer patients. We are excited about the underlying science behind OKN-007 and the opportunity to use our platform to generate evidence and accelerate OKN-007 development. ...
ByxCures
(Nasdaq: QLGN), a diversified life sciences company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug designation, while also commercializing diagnostics, today announces the mutual extension of a research agreement with University of Louisville Research Foundation (ULRF). ...
(Nasdaq: QLGN), a biotechnology company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, today announces that three abstracts on aspects of the Company’s recently in-licensed compound from University College -London, QN-302, have been accepted as posters to be presented at the prestigious American ...
(Nasdaq: QLGN), a biotechnology company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, today announced that it has engaged Professor Stephen Neidle as a scientific advisor. ...
(Nasdaq: QLGN), a biotechnology company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, today announces the exclusive worldwide in-license of a genomic quadruplex (G4)-selective transcription inhibitor drug development program, including lead and back-up compounds, preclinical data and a patent estate, ...
As we continue to achieve regulatory milestones that broaden the availability of glucarpidase globally, we grow more excited for Voraxaze’s potential to improve the care of cancer patients around the world.” In August of 2020 BTG submitted a Marketing Authorisation Application for Voraxaze® (glucarpidase) with the European Medicines Agency (EMA) for the treatment ...
(NASDAQ: QLGN), a biotechnology company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, announced today that CEO and Chairman Michael Poirier will present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit September 20-23, 2021. ...
(NASDAQ: QLGN), a biotechnology company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, announced today that CEO and Chairman Michael Poirier will present at the H.C. ...
Its four medical centers – Kapiolani, Pali Momi, Straub, and Wilcox – specialize in innovative programs in women’s health, pediatric care, cardiovascular services, cancer care, bone, and joint services, and more. ...
In 2006, the EPA awarded The Deirdre Imus Environmental Center for Pediatric Oncology at Hackensack University Medical Center an Environmental Quality Award, which recognizes outstanding contributions by organizations and individuals to protect public health and the environment. The center is one of the first hospital-based programs with the specific mission of identifying and ...
Jude is one of the world"s premier centers for the research and treatment of pediatric cancer and other catastrophic childhood diseases. St. Jude has developed protocols that have helped push overall survival rates for childhood cancers from less than 20 percent when the hospital opened in 1962 to 80 percent today. ...
Since 2009, the makers of Glad products have encouraged people to give back through its partnership with Cookies for Kids' Cancer, a non-profit organization committed to raising funds for pediatric cancer research through local bake sales. Pediatric cancer is the leading cause of death by disease for children ...